Annual D&A
$744.00 K
-$823.00 K-52.52%
31 December 2023
Summary:
Spyre Therapeutics annual depreciation & amortization is currently $744.00 thousand, with the most recent change of -$823.00 thousand (-52.52%) on 31 December 2023. During the last 3 years, it has fallen by -$832.00 thousand (-52.79%). SYRE annual D&A is now -52.79% below its all-time high of $1.58 million, reached on 01 December 2021.SYRE Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$0.00
$0.000.00%
30 September 2024
Summary:
Spyre Therapeutics quarterly depreciation & amortization is currently $0.00, unchanged on 30 September 2024. Over the past year, it has stayed the same.SYRE quarterly D&A is now -100.00% below its all-time high of $569.00 thousand, reached on 01 June 2022.SYRE Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
-$220.00 K
$0.000.00%
30 September 2024
Summary:
Spyre Therapeutics TTM depreciation & amortization is currently -$220.00 thousand, unchanged on 30 September 2024. Over the past year, it has dropped by -$1.28 million (-120.81%). SYRE TTM D&A is now -111.67% below its all-time high of $1.89 million, reached on 01 September 2022.SYRE TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYRE Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -52.5% | 0.0% | -120.8% |
| 3 y3 years | -52.8% | -100.0% | -114.0% |
| 5 y5 years | +78.0% | -100.0% | -152.6% |
SYRE Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -52.8% | at low | -100.0% | +100.0% | -111.7% | at low |
| 5 y | 5 years | -52.8% | +78.0% | -100.0% | +100.0% | -111.7% | at low |
| alltime | all time | -52.8% | +3815.8% | -100.0% | +100.0% | -111.7% | at low |
Spyre Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $0.00(0.0%) | -$220.00 K(0.0%) |
| June 2024 | - | $0.00(0.0%) | -$220.00 K(-212.2%) |
| Mar 2024 | - | $0.00(-100.0%) | $196.00 K(-73.7%) |
| Dec 2023 | $744.00 K(-52.5%) | -$220.00 K(<-9900.0%) | $744.00 K(-29.6%) |
| Sept 2023 | - | $0.00(-100.0%) | $1.06 M(-32.2%) |
| June 2023 | - | $416.00 K(-24.1%) | $1.56 M(-8.9%) |
| Mar 2023 | - | $548.00 K(+489.2%) | $1.71 M(+9.3%) |
| Dec 2022 | $1.57 M(-0.6%) | - | - |
| Dec 2022 | - | $93.00 K(-81.5%) | $1.57 M(-16.9%) |
| Sept 2022 | - | $502.00 K(-11.8%) | $1.89 M(+5.0%) |
| June 2022 | - | $569.00 K(+41.2%) | $1.79 M(+10.5%) |
| Mar 2022 | - | $403.00 K(-1.9%) | $1.62 M(+3.0%) |
| Dec 2021 | $1.58 M(+58.2%) | $411.00 K(-0.2%) | $1.58 M(+2.7%) |
| Sept 2021 | - | $412.00 K(+3.5%) | $1.53 M(+11.7%) |
| June 2021 | - | $398.00 K(+12.1%) | $1.37 M(+14.7%) |
| Mar 2021 | - | $355.00 K(-3.8%) | $1.20 M(+20.2%) |
| Dec 2020 | $996.00 K(+138.3%) | $369.00 K(+47.0%) | $996.00 K(+35.9%) |
| Sept 2020 | - | $251.00 K(+13.1%) | $733.00 K(+24.9%) |
| June 2020 | - | $222.00 K(+44.2%) | $587.00 K(+24.4%) |
| Mar 2020 | - | $154.00 K(+45.3%) | $472.00 K(+12.9%) |
| Dec 2019 | $418.00 K | $106.00 K(+1.0%) | $418.00 K(+8.9%) |
| Sept 2019 | - | $105.00 K(-1.9%) | $384.00 K(+8.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2019 | - | $107.00 K(+7.0%) | $355.00 K(+9.9%) |
| Mar 2019 | - | $100.00 K(+38.9%) | $323.00 K(+10.2%) |
| Dec 2018 | $293.00 K(+17.7%) | $72.00 K(-5.3%) | $293.00 K(+2.1%) |
| Sept 2018 | - | $76.00 K(+1.3%) | $287.00 K(+2.5%) |
| June 2018 | - | $75.00 K(+7.1%) | $280.00 K(+4.9%) |
| Mar 2018 | - | $70.00 K(+6.1%) | $267.00 K(+7.2%) |
| Dec 2017 | $249.00 K(+88.6%) | $66.00 K(-4.3%) | $249.00 K(+13.7%) |
| Sept 2017 | - | $69.00 K(+11.3%) | $219.00 K(+19.0%) |
| June 2017 | - | $62.00 K(+19.2%) | $184.00 K(+18.7%) |
| Mar 2017 | - | $52.00 K(+44.4%) | $155.00 K(+17.4%) |
| Dec 2016 | $132.00 K(+48.3%) | $36.00 K(+5.9%) | $132.00 K(+5.6%) |
| Sept 2016 | - | $34.00 K(+3.0%) | $125.00 K(+7.8%) |
| June 2016 | - | $33.00 K(+13.8%) | $116.00 K(+14.9%) |
| Mar 2016 | - | $29.00 K(0.0%) | $101.00 K(+13.5%) |
| Dec 2015 | $89.00 K(+368.4%) | $29.00 K(+16.0%) | $89.00 K(+23.6%) |
| Sept 2015 | - | $25.00 K(+38.9%) | $72.00 K(+38.5%) |
| June 2015 | - | $18.00 K(+5.9%) | $52.00 K(+48.6%) |
| Mar 2015 | - | $17.00 K(+41.7%) | $35.00 K(+84.2%) |
| Dec 2014 | $19.00 K | $12.00 K(+140.0%) | $19.00 K(+171.4%) |
| Sept 2014 | - | $5000.00(+400.0%) | $7000.00(+250.0%) |
| June 2014 | - | $1000.00(0.0%) | $2000.00(+100.0%) |
| Mar 2014 | - | $1000.00 | $1000.00 |
FAQ
- What is Spyre Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Spyre Therapeutics?
- What is Spyre Therapeutics annual D&A year-on-year change?
- What is Spyre Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Spyre Therapeutics?
- What is Spyre Therapeutics quarterly D&A year-on-year change?
- What is Spyre Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Spyre Therapeutics?
- What is Spyre Therapeutics TTM D&A year-on-year change?
What is Spyre Therapeutics annual depreciation & amortization?
The current annual D&A of SYRE is $744.00 K
What is the all time high annual D&A for Spyre Therapeutics?
Spyre Therapeutics all-time high annual depreciation & amortization is $1.58 M
What is Spyre Therapeutics annual D&A year-on-year change?
Over the past year, SYRE annual depreciation & amortization has changed by -$823.00 K (-52.52%)
What is Spyre Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of SYRE is $0.00
What is the all time high quarterly D&A for Spyre Therapeutics?
Spyre Therapeutics all-time high quarterly depreciation & amortization is $569.00 K
What is Spyre Therapeutics quarterly D&A year-on-year change?
Over the past year, SYRE quarterly depreciation & amortization has changed by $0.00 (0.00%)
What is Spyre Therapeutics TTM depreciation & amortization?
The current TTM D&A of SYRE is -$220.00 K
What is the all time high TTM D&A for Spyre Therapeutics?
Spyre Therapeutics all-time high TTM depreciation & amortization is $1.89 M
What is Spyre Therapeutics TTM D&A year-on-year change?
Over the past year, SYRE TTM depreciation & amortization has changed by -$1.28 M (-120.81%)